CLINICAL_TRIALS trial_result · 2011-06-17

Clinical Trial Update: A Study of Pulmozyme® (Dornase Alpha) in 3- to 5-Year-Old Patients With Cystic Fibrosis [Phase 4]

Phase 4 clinical trial of Pulmozyme (dornase alfa) in 3- to 5-year-old children with cystic fibrosis was terminated; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Genentech, Inc. | Conditions: Cystic Fibrosis | Phase 4 | Status: TERMINATED | Results posted: 2011-06-17